Compare MEDP & CX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MEDP | CX |
|---|---|---|
| Founded | 1992 | 1906 |
| Country | United States | Mexico |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Building Materials |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4B | 14.7B |
| IPO Year | 2016 | 1999 |
| Metric | MEDP | CX |
|---|---|---|
| Price | $543.83 | $10.83 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 7 |
| Target Price | ★ $465.18 | $10.52 |
| AVG Volume (30 Days) | 277.0K | ★ 7.3M |
| Earning Date | 10-22-2025 | 10-28-2025 |
| Dividend Yield | N/A | ★ 0.80% |
| EPS Growth | 25.36 | ★ 231.88 |
| EPS | ★ 14.32 | 0.09 |
| Revenue | $2,358,373,000.00 | ★ $15,869,840,000.00 |
| Revenue This Year | $21.48 | $2.25 |
| Revenue Next Year | $11.90 | $5.11 |
| P/E Ratio | $38.28 | ★ $11.48 |
| Revenue Growth | ★ 13.88 | N/A |
| 52 Week Low | $250.05 | $4.89 |
| 52 Week High | $626.26 | $11.05 |
| Indicator | MEDP | CX |
|---|---|---|
| Relative Strength Index (RSI) | 36.48 | 63.11 |
| Support Level | $530.96 | $10.00 |
| Resistance Level | $626.26 | $10.84 |
| Average True Range (ATR) | 18.24 | 0.27 |
| MACD | -8.14 | 0.04 |
| Stochastic Oscillator | 17.60 | 80.72 |
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Cemex SAB de CV is a ready-mix concrete company that mainly engaged in activities that are oriented to the construction industry, mainly through the production, marketing, sale, and distribution of cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and also provide related services and reliable construction-related services to customers and communities and maintain business relationships in more than 60 countries throughout the world. The company operates in different parts of the world, with operations in Mexico, the United States, the EMEA region and the SCA&C region.